Lloyds Banking Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$40K Sell
943
-24
-2% -$1.2K 0.56% 40
2018
Q3
$54K Sell
967
-1,163
-55% -$61.2K 0.66% 42
2018
Q2
$107K Sell
2,130
-1,970
-48% -$103K 0.88% 44
2018
Q1
$204K Sell
4,100
-344
-8% -$16.2K 1.58% 16
2017
Q4
$182K Hold
4,444
1.69% 22
2017
Q3
$132K Sell
4,444
-455
-9% -$13.9K 1.32% 35
2017
Q2
$162K Sell
4,899
-1,928
-28% -$60.6K 1.57% 30
2017
Q1
$202K Sell
6,827
-1,629
-19% -$44.5K 1.82% 21
2016
Q4
$209K Sell
8,456
-6
-0.1% -$136 1.82% 27
2016
Q3
$190K Sell
8,462
-157
-2% -$3.69K 1.71% 32
2016
Q2
$205K Hold
8,619
1.69% 30
2016
Q1
$204K Buy
+8,619
New +$211K 1.66% 33

Other funds holding GMED

Lloyds Banking Group's GMED Position: Q4 2018 in Review

Lloyds Banking Group reduced its Globus Medical (GMED) stake by 2.5% in Q4 2018, selling an estimated $1.2K and leaving 943 shares worth $40K. The position accounts for 0.56% of the portfolio, ranked #40.

Lloyds Banking Group first reported a position in GMED in Q1 2016 and has held it in 12 quarters since. The position peaked at $209K in Q4 2016. 303 funds tracked by Wall St. Rank hold GMED as of Q4 2018.

  • Lloyds Banking Group held 943 shares of Globus Medical worth $40K as of Q4 2018.
  • Lloyds Banking Group sold 24 Globus Medical shares in Q4 2018, an estimated $1.2K.
  • Globus Medical made up 0.56% of Lloyds Banking Group's portfolio in Q4 2018, its #40 holding.
  • Lloyds Banking Group first reported a position in Globus Medical in Q1 2016 and has held it in 12 quarters since.
  • Lloyds Banking Group's Globus Medical position peaked at $209K in Q4 2016.
  • 303 funds tracked by Wall St. Rank held Globus Medical as of Q4 2018.

Based on Lloyds Banking Group's 13F filing for Q4 2018, filed 11 Feb 2019.